Schonfeld Strategic Advisors’s Endologix Inc ELGX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-25,000	Closed	-$1.34M	–	1066
2017 Q4	$1.34M	Buy	25,000 +1,500	+6%	+$79.2K	0.11%	253
2017 Q3	$1.05M	Buy	+23,500	New	+$1.07M	0.1%	257
2017 Q2	–	Sell	-3,334	Closed	-$241K	–	860
2017 Q1	$241K	Sell	3,334 -4,901	-60%	-$324K	0.02%	514
2016 Q4	$471K	Buy	+8,235	New	+$754K	0.06%	348
2016 Q3	–	Sell	-1,034	Closed	-$129K	–	609
2016 Q2	$129K	Buy	+1,034	New	+$119K	0.03%	402

Other funds holding ELGX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Schonfeld Strategic Advisors's ELGX Position: Q1 2018 in Review

Schonfeld Strategic Advisors sold out of Endologix Inc (ELGX) in Q1 2018, closing a stake of 25,000 shares — an estimated $1.34M sold.

Schonfeld Strategic Advisors first reported a position in ELGX in Q2 2016 and held it in 5 quarters. The position peaked at $1.34M in Q4 2017. 97 funds tracked by Wall St. Rank hold ELGX as of Q1 2018.

Schonfeld Strategic Advisors reported no remaining Endologix Inc position as of Q1 2018 after selling out during the quarter.
Schonfeld Strategic Advisors sold 25,000 Endologix Inc shares in Q1 2018, an estimated $1.34M.
Schonfeld Strategic Advisors first reported a position in Endologix Inc in Q2 2016 and held it in 5 quarters.
Schonfeld Strategic Advisors's Endologix Inc position peaked at $1.34M in Q4 2017.
97 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2018.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2018, filed 15 May 2018.